Investments
2Portfolio Exits
1Partners & Customers
1Latest NKY PHARMA News
Oct 20, 2021
Key Topics in this News Article: News Snapshot: 2020 Edition Report with Impact of COVID-19 on Cyclohexylpyrrolidone Market BASF, NKY PHARMA, Ashland and Hangzhou Ocean Chemical Market.Biz Leading Research Firm has added latest report with Impact of COVID-19 on the Global Cyclohexylpyrrolidone Market by Manufacturers, Regions, Type and Application, Forecast to 2026. Global Cyclohexylpyrrolidone Market Report 2020-2026 The report titled Cyclohexylpyrrolidone Market gives a proper understanding of Chemicals and Materials industry. Furthermore it also cover-up forecast and analysis for market on the global and regional level. The report analyses market on basis of its attractiveness and investment feasibility. It also presents proper description of every section and emerging...
NKY PHARMA Investments
2 Investments
NKY PHARMA has made 2 investments. Their latest investment was in HuaDao CAR-Tcell as part of their Series B on July 7, 2019.
NKY PHARMA Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/27/2019 | Series B | HuaDao CAR-Tcell | $11.62M | Yes | 3 | |
4/4/2019 | Corporate Minority |
Date | 7/27/2019 | 4/4/2019 |
|---|---|---|
Round | Series B | Corporate Minority |
Company | HuaDao CAR-Tcell | |
Amount | $11.62M | |
New? | Yes | |
Co-Investors | ||
Sources | 3 |
NKY PHARMA Portfolio Exits
1 Portfolio Exit
NKY PHARMA has 1 portfolio exit. Their latest portfolio exit was BioVision on August 02, 2021.
NKY PHARMA Acquisitions
1 Acquisition
NKY PHARMA acquired 1 company. Their latest acquisition was BioVision on December 12, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
12/12/2017 | Corporate Majority | 1 |
Date | 12/12/2017 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Corporate Majority |
Sources | 1 |
NKY PHARMA Partners & Customers
1 Partners and customers
NKY PHARMA has 1 strategic partners and customers. NKY PHARMA recently partnered with Abcam on October 10, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
10/28/2021 | Vendor | United Kingdom | China’s Boai NKY Soars on Deal With UK’s Abcam to Supply Customized Reagents Oct. 28 -- Shares in Boai NKY surged as much as 11 percent today after the Chinese pharmaceutics firm said it has signed a five-year deal with the UK 's life science research tools supplier Abcam to provide it with biological reagent raw materials for its in vitro diagnostic products as well as support in their commercialization . | 1 |
Date | 10/28/2021 |
|---|---|
Type | Vendor |
Business Partner | |
Country | United Kingdom |
News Snippet | China’s Boai NKY Soars on Deal With UK’s Abcam to Supply Customized Reagents Oct. 28 -- Shares in Boai NKY surged as much as 11 percent today after the Chinese pharmaceutics firm said it has signed a five-year deal with the UK 's life science research tools supplier Abcam to provide it with biological reagent raw materials for its in vitro diagnostic products as well as support in their commercialization . |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.